SLAYBACK PHARMA INDIA LLP

Nature of Business: Pharmaceutical Developer and Commercializer

Description:

SLAYBACK PHARMA INDIA LLP is a pharmaceutical company focused on the development and commercialization of complex generic pharmaceutical products. The company specializes in identifying, developing, and bringing to market difficult-to-formulate and niche generic products. Their operations encompass research and development, formulation development, regulatory submissions, and commercialization strategies. They often collaborate with manufacturing partners or utilize contract manufacturing organizations (CMOs) for the production of their developed products, ensuring high-quality standards and market supply.

Type (Factory/Trader):

SLAYBACK PHARMA INDIA LLP is primarily a pharmaceutical developer and commercializer. While they may leverage contract manufacturing organizations (CMOs) for the actual production of their drugs, their core business involves the intellectual property, development, and market introduction of pharmaceutical products. They are significantly involved in the manufacturing process through oversight, quality assurance, and supply chain management, rather than being a pure trader of third-party finished goods without proprietary development.

SLAYBACK PHARMA INDIA LLP manufactures and sells a variety of pharmaceutical products, including:

* **Active Pharmaceutical Ingredients (APIs):** Specifically, APIs for drugs used in the treatment of conditions such as:

* Gastrointestinal disorders

* Cardiovascular diseases

* Central nervous system disorders

* Anti-infectives

* Anti-diabetics

* **Finished Dosage Formulations (FDFs):** Including tablets, capsules, and oral liquids.

* **Generics:** Focused on providing affordable generic versions of established medications.